These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3998718)

  • 1. Ethnicity and reporting of schizophrenic symptoms.
    Randolph ET; Escobar JI; Paz DH; Forsythe AB
    J Nerv Ment Dis; 1985 Jun; 173(6):332-40. PubMed ID: 3998718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NIMH-DIS in the assessment of DSM-III schizophrenic disorder.
    Escobar JI; Randolph ET; Asamen J; Karno M
    Schizophr Bull; 1986; 12(2):187-94. PubMed ID: 3715414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two interview schedules. The Schedule for Affective Disorders and Schizophrenia-Lifetime and the National Institute for Mental Health Diagnostic Interview Schedule.
    Hesselbrock V; Stabenau J; Hesselbrock M; Mirkin P; Meyer R
    Arch Gen Psychiatry; 1982 Jun; 39(6):674-7. PubMed ID: 7092500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French translation of the Chapman Social and Physical Anhedonia Questionnaire: validation of the French translation in controls and schizophrenic patients].
    Assouly-Besse F; Dollfus S; Petit M
    Encephale; 1995; 21(4):273-84. PubMed ID: 7588166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Spanish-language version of the National Institute of Mental Health Diagnostic Interview Schedule.
    Karno M; Burnam A; Escobar JI; Hough RL; Eaton WW
    Arch Gen Psychiatry; 1983 Nov; 40(11):1183-8. PubMed ID: 6639287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues in selection of instruments to measure negative symptoms.
    Daniel DG
    Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity and negative symptoms in patients with schizophrenia.
    Dassori AM; Miller AL; Velligan D; Saldana D; Diamond P; Mahurin R
    Cult Divers Ment Health; 1998; 4(1):65-9. PubMed ID: 9458593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Borderline Syndrome Index. Clinical validity and utility.
    Edell WS
    J Nerv Ment Dis; 1984 May; 172(5):254-63. PubMed ID: 6716090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Spanish Diagnostic Interview Schedule. Reliability and comparison with clinical diagnoses.
    Burnam MA; Karno M; Hough RL; Escobar JI; Forsythe AB
    Arch Gen Psychiatry; 1983 Nov; 40(11):1189-96. PubMed ID: 6639288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of major mental disorders in an US metropolis.
    Escobar JI; Karno M; Burnam A; Hough RL; Golding J
    Acta Psychiatr Scand Suppl; 1988; 344():45-53. PubMed ID: 3265847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining and measuring negative symptoms of schizophrenia in clinical trials.
    Marder SR; Kirkpatrick B
    Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome.
    Tien AY; Eaton WW
    Arch Gen Psychiatry; 1992 Jan; 49(1):37-46. PubMed ID: 1728250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the computerized DIS for diagnosing psychiatric inpatients.
    Levitan RD; Blouin AG; Navarro JR; Hill J
    Can J Psychiatry; 1991 Dec; 36(10):728-31. PubMed ID: 1790517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nosologic specificity of psychopathologic findings in schizophrenic and depressed patients].
    Schneider F; Böser H; Heimann H; Fus I; Friedrich J
    Wien Klin Wochenschr; 1992; 104(3):51-5. PubMed ID: 1570706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore.
    Anthony JC; Folstein M; Romanoski AJ; Von Korff MR; Nestadt GR; Chahal R; Merchant A; Brown CH; Shapiro S; Kramer M
    Arch Gen Psychiatry; 1985 Jul; 42(7):667-75. PubMed ID: 4015308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rating depression in schizophrenia. A comparison of a self-report and an observer report scale.
    Addington D; Addington J; Maticka-Tyndale E
    J Nerv Ment Dis; 1993 Sep; 181(9):561-5. PubMed ID: 8245924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing positive and negative symptoms in children and adolescents.
    Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
    Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of the Whitaker Index of Schizophrenic Thinking (WIST) in a Mexican population: a multivariable study.
    Ornelas Bolado AL; Whitaker LC
    J Clin Psychol; 1990 Mar; 46(2):140-7. PubMed ID: 2324297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.